Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Venous Thromboembolism (VTE)145.35M94.76%
Emerging Therapies8.04M5.24%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States469.86M95.19%
International23.77M4.81%